Atreca Inc. is a biopharmaceutical company that develops novel therapeutics utilizing their proprietary drug discovery platform. Their platform identifies and targets antibodies against clinically significant, yet undiscovered, tumor antigens. With a focus on oncology, Atreca aims to provide groundbreaking treatments for patients in need.
Notification